Trial Condition(s):

Atopic dermatitis

Methylprednisolone aceponate ointment (1 x daily plus compound-free ointment base 1 x daily) in comparison to Dermatop in children with atopic dermatitis to evaluate relative efficacy and safety

Bayer Identifier:

Trial_89160

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

109

Trial Dates

January1990

March1991

Phase

Could I receive a placebo?

Products

Advantan (Methylprednisolone Aceponate, BAY86-4862)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

For details, please refer to trial results

Additional Information

Not Available

Atopic dermatitis

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

4 Months

14 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information